CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 64 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,769,000 | -3.7% | 285,765 | 0.0% | 0.90% | -29.7% |
| Q2 2020 | $1,837,000 | +54.9% | 285,765 | 0.0% | 1.27% | +28.0% |
| Q1 2020 | $1,186,000 | -29.8% | 285,765 | 0.0% | 1.00% | -2.7% |
| Q4 2019 | $1,689,000 | +9.5% | 285,765 | 0.0% | 1.02% | -5.6% |
| Q3 2019 | $1,543,000 | -33.1% | 285,765 | 0.0% | 1.08% | -30.0% |
| Q2 2019 | $2,306,000 | +1.9% | 285,765 | 0.0% | 1.55% | +16.7% |
| Q1 2019 | $2,263,000 | – | 285,765 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |